Review of the microscopic colitides

Current Gastroenterology Reports

Volumn 13, Issue 5, 2011, Pages 458-464

  Yen, Eugene F ^b   Pardi, Darrell S ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Collagenous colitis; Lymphocytic colitis; Microscopic colitis

Indexed keywords

ACETYLSALICYLIC ACID; ATROPINE PLUS DIPHENOXYLATE; AZATHIOPRINE; BILE ACID; BISMUTH SALICYLATE; BUDESONIDE; CARBAMAZEPINE; COLESTYRAMINE; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; TICLOPIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL PAIN; AUTOIMMUNITY; BILE ACID MALABSORPTION; CELIAC DISEASE; CHRONIC DIARRHEA; CLINICAL FEATURE; COLLAGENOUS COLITIS; COLON BIOPSY; COLON RESECTION; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE ASSOCIATION; ENTERITIS; EPIDEMIOLOGICAL DATA; FECES INCONTINENCE; HISTOPATHOLOGY; HUMAN; ILEOANAL ANASTOMOSIS; ILEOSTOMY; INCIDENCE; LOW DRUG DOSE; LYMPHOCYTIC COLITIS; MALABSORPTION; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL HISTORY; MICROSCOPIC COLITIS; PATHOPHYSIOLOGY; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RETROSPECTIVE STUDY; REVIEW; SIGMOIDOSCOPY;

COLITIS, MICROSCOPIC; DIARRHEA; HUMANS;

EID: 80755130576     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-011-0207-7     Document Type: Review

References (63)

1. Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175-81. (Pubitemid 46806226)
2. Chey WD, Nojkov B, Rubenstein JH, et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 105:859-65. The first study to prospectively evaluate the yield of colonoscopy in patients with irritable bowel syndrome symptoms, with 2.3% of patients over age 45 being diagnosed with microscopic colitis.
3. Yen EF, Pokhrel B, Bianchi LK, et al. Concomitant adenoma rates in patients with microscopic colitis. Gastroenterology. 2009;136: A-20.
4. Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 2004;53:536-41. (Pubitemid 38372978)
5. Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122-8. (Pubitemid 34439192)
6. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut. 1995;37:394-7.
7. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846-51. (Pubitemid 27049088)
8. Gremse DA, Boudreaux CW, Manci EA. Collagenous colitis in children. Gastroenterology. 1993;104:906-9. (Pubitemid 23059593)
9. Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis. 2005;20:312-6. (Pubitemid 40909227)
10. Hjortswang H, Tysk C, Bohr J, et al. Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis. 2010;43:102-9. A cross sectional study with 116 patients with collagenous colitis, the first major paper to illustrate the extent of quality of life impairment in patients with microscopic colitis.
11. Baert F, Wouters K, D'Haens G, et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut. 1999;45:375-81. (Pubitemid 29400713)
12. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebocontrolled, multicenter trial. Gastroenterology. 2002;123:978-84.
13. Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248-51. (Pubitemid 36115067)
14. Baert F, Schmit A, D'Haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002;122:20-5. (Pubitemid 34049190)
15. Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 2009;136:2092-100. The preceding four studies (16-19) represent the largest randomized placebo-controlled studies to date on the treatment of microscopic colitis, all using budesonide.
16. Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;135:1510-6.
17. Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut. 2009;58:68-72. The preceding 2 studies are placebo-controlled studies involving budesonide for maintenance of remission in microscopic colitis.
18. Chan JL, Tersmette AC, Offerhaus GJ, et al. Cancer risk in collagenous colitis. Inflamm Bowel Dis. 1999;5:40-3.
19. Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009;15:3122-7.
20. Pardi DS, Ramnath VR, Loftus Jr EV, et al. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;97:2829-33. (Pubitemid 35265435)
21. Wolber R, Owen D, Freeman H. Colonic lymphocytosis in patients with celiac sprue. Hum Pathol. 1990;21:1092-6. (Pubitemid 20381990)
22. Green PH, Yang J, Cheng J, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol. 2009;7:1210-6.
23. Bohr J, Tysk C, Yang P, et al. Autoantibodies and immunoglobulins in collagenous colitis. Gut. 1996;39:73-6. (Pubitemid 26239109)
24. Fine KD, Do K, Schulte K, et al. High prevalence of celiac spruelike HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol. 2000;95:1974-82.
25. Pardi DS, Loftus Jr EV, Kammer PP, et al. Collagenous colitis, but not lymphocytic colitis, is associated with cigarette smoking [abstract]. Am J Gastroenterol. 2004;99:S116.
26. Pokhrel B, Witt B, Bianchi LK, et al. Microscopic colitis and association with cigarette smoking and alcohol intake [abstract]. Am J Gastroenterol. 2009;104:S453-4.
27. Jarnerot G, Tysk C, Bohr J, et al. Collagenous colitis and fecal stream diversion. Gastroenterology. 1995;109:449-55.
28. Mosnier JF, Larvol L, Barge J, et al. Lymphocytic and collagenous colitis: an immunohistochemical study. Am J Gastroenterol. 1996;91:709-13. (Pubitemid 126733806)
29. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277-84. (Pubitemid 41207456)
30. Fernandez-Banares F, Esteve M, Espinos JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007;102:324-30. (Pubitemid 46160546)
31. Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal antiinflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut. 1992;33:683-6.
32. Bjarnason I, Hayllar J, MacPherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832-47. (Pubitemid 23235480)
33. Yagi K, Nakamura A, Sekine A, et al. Nonsteroidal antiinflammatory drug-associated colitis with a histology of collagenous colitis. Endoscopy. 2001;33:629-32. (Pubitemid 32618933)
34. Al-Ghamdi MY, Malatjalian DA, Veldhuyzen van Zanten S. Causation: recurrent collagenous colitis following repeated use of NSAIDs. Can J Gastroenterol. 2002;16:861-2.
35. Pascua MF, Kedia P, Weiner M, et al. Microscopic colitis and medication use. Gastroenterology. 2009;136:A-366.
36. Pignone M, Anderson GK, Binns K, et al. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med. 2007;32:403-7.
37. Lundberg JO, Herulf M, Olesen M, et al. Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest. 1997;27:869-71. (Pubitemid 27460626)
38. Olesen M, Middelveld R, Bohr J, et al. Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand J Gastroenterol. 2003;38:66-72. (Pubitemid 36152867)
39. Perner A, Andresen L, Normark M, et al. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut. 2001;49:387-94. (Pubitemid 32802574)
40. Burgel N, Bojarski C, Mankertz J, et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology. 2002;123:433-43. (Pubitemid 34827187)
41. Marteau P, Lavergne-Slove A, Lemann M, et al. Primary ileal villous atrophy is often associated with microscopic colitis. Gut. 1997;41:561-4. (Pubitemid 27448793)
42. Ung KA, Gillberg R, Kilander A, et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut. 2000;46:170-5. (Pubitemid 30305841)
43. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523-6. (Pubitemid 36363405)
44. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in postdysenteric irritable bowel syndrome. Gut. 2000;47:804-11.
45. Aigner T, Neureiter D, Muller S, et al. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology. 1997;113:136-43. (Pubitemid 27281767)
46. Salas A, Fernandez-Banares F, Casalots J, et al. Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology. 2003;43:48-54. (Pubitemid 36836587)
47. Lee E, Schiller LR, Vendrell D, et al. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology. 1992;103: 1790-6.
48. Couto G, Bispo M, Barreiro P, et al. Unique endoscopy findings in collagenous colitis. Gastrointest Endosc. 2009;69:1186-8.
49. Carmack SW, Lash RH, Gulizia JM, et al. Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol. 2009;16:290-306. A thorough update of the etiologies of lymphocytic infiltration in the GI tract, reviewing that intra-epithelial lymphocytes can be associated with conditions other than microscopic colitis.
50. Fine KD, Lee EL, Meyer RL. Colonic histopathology in untreated celiac sprue or refractory sprue: is it lymphocytic colitis or colonic lymphocytosis? Hum Pathol. 1998;29:1433-40. (Pubitemid 28563976)
51. Matteoni CA, Wang N, Goldblum JR, et al. Flexible sigmoidoscopy for the detection of microscopic colitis. Am JMed. 2000;108:416-8. (Pubitemid 30162960)
52. Tanaka M, Mazzoleni G, Riddell RH. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut. 1992;33:65-70.
53. Thijs WJ, van Baarlen J, Kleibeuker JH, et al. Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med. 2005;63:137-40. (Pubitemid 40561529)
54. Yen EF, Hall CR, Witt B. Yield of sigmoid and rectal biopsies in the detection of microscopic colitis. Gastroenterology. 2010;138: S638.
55. Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology. 1998; 114:29-36. (Pubitemid 28020951)
56. Fernandez-Banares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci. 2001;46:2231-8. (Pubitemid 32955237)
57. Calabrese C, Fabbri A, Areni A, et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol. 2007;22:809-14. (Pubitemid 46911015)
58. Abdalla AA, Faubion WA, Loftus Jr EV, et al. The natural history of microscopic colitis treated with corticosteroids [abstract]. Gastroenterology. 2008;134:A121.
59. Munck LK, Kjeldsen J, Philipsen E, et al. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol. 2003;38:606-10. (Pubitemid 36724039)
60. Pardi DS, Loftus Jr EV, Tremaine WJ, et al. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 2001;120:1483-4. (Pubitemid 32322323)
61. Rodriguez E, Mahadevan U. Anti-TNF therapy for refractory microscopic colitis. Gastroenterology. 2009;136:A663.
62. Jarnerot G, Bohr J, Tysk C, et al. Faecal stream diversion in patients with collagenous colitis. Gut. 1996;38:154-5. (Pubitemid 26020945)
63. Williams RA, Gelfand DV. Total proctocolectomy and ileal pouch anal anastomosis to successfully treat a patient with collagenous colitis. Am J Gastroenterol. 2000;95:2147. (Pubitemid 30629344)